Nutraceuticals Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Nutraceuticals Market is expected to grow from USD 219,676.72 Million in 2020 to USD 319,932.70 Million by the end of 2025.
2. The Global Nutraceuticals Market is expected to grow from EUR 192,616.72 Million in 2020 to EUR 280,523.07 Million by the end of 2025.
3. The Global Nutraceuticals Market is expected to grow from GBP 171,236.68 Million in 2020 to GBP 249,385.62 Million by the end of 2025.
4. The Global Nutraceuticals Market is expected to grow from JPY 23,445,073.05 Million in 2020 to JPY 34,144,926.78 Million by the end of 2025.
5. The Global Nutraceuticals Market is expected to grow from AUD 318,999.82 Million in 2020 to AUD 464,584.83 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Nutraceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Geography, the Nutraceuticals Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Nutraceuticals Market including Ajinomoto Co., Inc., Archer Daniels Midland Company, Arla Foods, Associated British Foods plc, BASF SE, Cargill Incorporated, Chr. Hansen A/S, DuPont de Nemours, Inc., Fonterra Co-Operative Group Limited, Glanbia Plc, Ingredion Inc., Kerry Group plc, Koninklijke DSM N.V., Kyowa Kirin Co., Ltd., and Tate & Lyle PLC.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Nutraceuticals Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Nutraceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nutraceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nutraceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Nutraceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Nutraceuticals Market?
6. What are the modes and strategic moves considered suitable for entering the Global Nutraceuticals Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Nutraceuticals Market is expected to grow from USD 219,676.72 Million in 2020 to USD 319,932.70 Million by the end of 2025.
2. The Global Nutraceuticals Market is expected to grow from EUR 192,616.72 Million in 2020 to EUR 280,523.07 Million by the end of 2025.
3. The Global Nutraceuticals Market is expected to grow from GBP 171,236.68 Million in 2020 to GBP 249,385.62 Million by the end of 2025.
4. The Global Nutraceuticals Market is expected to grow from JPY 23,445,073.05 Million in 2020 to JPY 34,144,926.78 Million by the end of 2025.
5. The Global Nutraceuticals Market is expected to grow from AUD 318,999.82 Million in 2020 to AUD 464,584.83 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Nutraceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Geography, the Nutraceuticals Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Nutraceuticals Market including Ajinomoto Co., Inc., Archer Daniels Midland Company, Arla Foods, Associated British Foods plc, BASF SE, Cargill Incorporated, Chr. Hansen A/S, DuPont de Nemours, Inc., Fonterra Co-Operative Group Limited, Glanbia Plc, Ingredion Inc., Kerry Group plc, Koninklijke DSM N.V., Kyowa Kirin Co., Ltd., and Tate & Lyle PLC.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Nutraceuticals Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Nutraceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nutraceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nutraceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Nutraceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Nutraceuticals Market?
6. What are the modes and strategic moves considered suitable for entering the Global Nutraceuticals Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Geography Outlook
3.4. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased life expectancy and health awareness among consumers
5.1.1.2. Growing demand for nutraceuticals with medical benefits
5.1.1.3. Growing preference for personalized nutrition
5.1.1.4. Growing demand in emerging economies
5.1.2. Restraints
5.1.2.1. Low awareness about nutraceuticals and higher costs of fortified and enriched products
5.1.3. Opportunities
5.1.3.1. Gradual adoption of probiotic and prebiotic food products as part of personalized diet
5.1.3.2. Innovations and findings of function-specific antioxidants
5.1.3.3. Gradually increasing healthcare expenditure
5.1.4. Challenges
5.1.4.1. High R&D cost of development
5.1.4.2. Varying regulatory standards in different countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. AMERICAS NUTRACEUTICALS MARKET
6.1. Introduction
6.2. Argentina
6.3. Brazil
6.4. Canada
6.5. Mexico
6.6. United States
7. ASIA-PACIFIC NUTRACEUTICALS MARKET
7.1. Introduction
7.2. Australia
7.3. China
7.4. India
7.5. Indonesia
7.6. Japan
7.7. Malaysia
7.8. Philippines
7.9. South Korea
7.10. Thailand
8. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET
8.1. Introduction
8.2. France
8.3. Germany
8.4. Italy
8.5. Netherlands
8.6. Qatar
8.7. Russia
8.8. Saudi Arabia
8.9. South Africa
8.10. Spain
8.11. United Arab Emirates
8.12. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. Market Ranking Analysis
9.3. Market Share Analysis
9.4. Competitor SWOT Analysis
9.5. Competitive Scenario
9.5.1. Merger & Acquisition
9.5.2. Agreement, Collaboration, & Partnership
9.5.3. New Product Launch & Enhancement
9.5.4. Investment & Funding
9.5.5. Award, Recognition, & Expansion
10. COMPANY USABILITY PROFILES
10.1. Ajinomoto Co., Inc.
10.2. Archer Daniels Midland Company
10.3. Arla Foods
10.4. Associated British Foods plc
10.5. BASF SE
10.6. Cargill Incorporated
10.7. Chr. Hansen A/S
10.8. DuPont de Nemours, Inc.
10.9. Fonterra Co-Operative Group Limited
10.10. Glanbia Plc
10.11. Ingredion Inc.
10.12. Kerry Group plc
10.13. Koninklijke DSM N.V.
10.14. Kyowa Kirin Co., Ltd.
10.15. Tate & Lyle PLC
11. APPENDIX
11.1. Discussion Guide
11.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Geography Outlook
3.4. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased life expectancy and health awareness among consumers
5.1.1.2. Growing demand for nutraceuticals with medical benefits
5.1.1.3. Growing preference for personalized nutrition
5.1.1.4. Growing demand in emerging economies
5.1.2. Restraints
5.1.2.1. Low awareness about nutraceuticals and higher costs of fortified and enriched products
5.1.3. Opportunities
5.1.3.1. Gradual adoption of probiotic and prebiotic food products as part of personalized diet
5.1.3.2. Innovations and findings of function-specific antioxidants
5.1.3.3. Gradually increasing healthcare expenditure
5.1.4. Challenges
5.1.4.1. High R&D cost of development
5.1.4.2. Varying regulatory standards in different countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. AMERICAS NUTRACEUTICALS MARKET
6.1. Introduction
6.2. Argentina
6.3. Brazil
6.4. Canada
6.5. Mexico
6.6. United States
7. ASIA-PACIFIC NUTRACEUTICALS MARKET
7.1. Introduction
7.2. Australia
7.3. China
7.4. India
7.5. Indonesia
7.6. Japan
7.7. Malaysia
7.8. Philippines
7.9. South Korea
7.10. Thailand
8. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET
8.1. Introduction
8.2. France
8.3. Germany
8.4. Italy
8.5. Netherlands
8.6. Qatar
8.7. Russia
8.8. Saudi Arabia
8.9. South Africa
8.10. Spain
8.11. United Arab Emirates
8.12. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. Market Ranking Analysis
9.3. Market Share Analysis
9.4. Competitor SWOT Analysis
9.5. Competitive Scenario
9.5.1. Merger & Acquisition
9.5.2. Agreement, Collaboration, & Partnership
9.5.3. New Product Launch & Enhancement
9.5.4. Investment & Funding
9.5.5. Award, Recognition, & Expansion
10. COMPANY USABILITY PROFILES
10.1. Ajinomoto Co., Inc.
10.2. Archer Daniels Midland Company
10.3. Arla Foods
10.4. Associated British Foods plc
10.5. BASF SE
10.6. Cargill Incorporated
10.7. Chr. Hansen A/S
10.8. DuPont de Nemours, Inc.
10.9. Fonterra Co-Operative Group Limited
10.10. Glanbia Plc
10.11. Ingredion Inc.
10.12. Kerry Group plc
10.13. Koninklijke DSM N.V.
10.14. Kyowa Kirin Co., Ltd.
10.15. Tate & Lyle PLC
11. APPENDIX
11.1. Discussion Guide
11.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NUTRACEUTICALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NUTRACEUTICALS MARKET: SCORES
TABLE 8. GLOBAL NUTRACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 9. GLOBAL NUTRACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 10. GLOBAL NUTRACEUTICALS MARKET: RANKING
TABLE 11. GLOBAL NUTRACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 12. GLOBAL NUTRACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 13. GLOBAL NUTRACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 14. GLOBAL NUTRACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 15. GLOBAL NUTRACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 16. GLOBAL NUTRACEUTICALS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NUTRACEUTICALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NUTRACEUTICALS MARKET: SCORES
TABLE 8. GLOBAL NUTRACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 9. GLOBAL NUTRACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 10. GLOBAL NUTRACEUTICALS MARKET: RANKING
TABLE 11. GLOBAL NUTRACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 12. GLOBAL NUTRACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 13. GLOBAL NUTRACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 14. GLOBAL NUTRACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 15. GLOBAL NUTRACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 16. GLOBAL NUTRACEUTICALS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL NUTRACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NUTRACEUTICALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NUTRACEUTICALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 5. GLOBAL NUTRACEUTICALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 6. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 7. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 9. GLOBAL NUTRACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 10. GLOBAL NUTRACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 11. AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 12. AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 15. BRAZIL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 16. CANADA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 17. MEXICO NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 18. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. AUSTRALIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CHINA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. INDIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. INDONESIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. JAPAN NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. MALAYSIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. PHILIPPINES NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. SOUTH KOREA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. THAILAND NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. FRANCE NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. GERMANY NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. ITALY NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. QATAR NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. RUSSIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SPAIN NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. GLOBAL NUTRACEUTICALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 46. GLOBAL NUTRACEUTICALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 47. GLOBAL NUTRACEUTICALS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 48. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NUTRACEUTICALS MARKET, BY TYPE
FIGURE 1. GLOBAL NUTRACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NUTRACEUTICALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NUTRACEUTICALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 5. GLOBAL NUTRACEUTICALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 6. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 7. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 9. GLOBAL NUTRACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 10. GLOBAL NUTRACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 11. AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 12. AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 15. BRAZIL NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 16. CANADA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 17. MEXICO NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 18. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. AUSTRALIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CHINA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. INDIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. INDONESIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. JAPAN NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. MALAYSIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. PHILIPPINES NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. SOUTH KOREA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. THAILAND NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. FRANCE NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. GERMANY NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. ITALY NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. QATAR NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. RUSSIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SPAIN NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. GLOBAL NUTRACEUTICALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 46. GLOBAL NUTRACEUTICALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 47. GLOBAL NUTRACEUTICALS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 48. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NUTRACEUTICALS MARKET, BY TYPE
